Barry Posner (physician)

Last updated
Barry Innis Posner
Born (1937-11-07) November 7, 1937 (age 86)
Alma mater University of Manitoba (MD)
Awards Order of Canada
Scientific career
Institutions McGill University

Barry Innis Posner, OC CQ FRSC (born November 7, 1937) is a Canadian physician, research scientist and Professor Emeritus in the Departments of Medicine and Anatomy & Cell Biology at McGill University, where he also managed the Polypeptide and Protein Hormone Laboratory.

Contents

Biography

Born in Winnipeg, Manitoba, he received his Doctor of Medicine degree from the University of Manitoba in 1961. A gold medalist in his graduating class, Posner pursued post-graduate work at the Massachusetts Institute of Technology and the National Institutes of Health in Bethesda, Maryland before joining the Royal Victoria Hospital and the McGill University Faculty of Medicine in 1970 as an assistant professor. He was appointed to the ranks of Associate Professor in 1975 and Professor in 1979. He was the Director of the Polypeptide Hormone Laboratory at McGill University and a Professor in the Department of Medicine and the Department of Anatomy and Cell Biology, as well as senior physician at the Royal Victoria Hospital. He has served as Director of the McGill Endocrine training program and physician-in-chief at the Sir Mortimer B. Davis Jewish General Hospital from 1996 to 2002.

Research

His fundamental research on insulin signaling led to the discovery of the endosomal system and the view that this is a central site for both initiating and regulating signal transduction. In the late 1980s, he discovered the peroxovanadium compounds as potent insulin mimetics; and in elucidating their mechanism of action, he defined the key role of phosphotyrosine phosphatases in regulating receptor tyrosine kinases. His group went on to define the role of lipid rafts as sites of intense signaling at both the cell surface and within endosomes. More recently Posner's diabetes research focused on the genes responsible for diabetes, the discovery of which will aid in the prediction and treatment of this disease.

Publications and scholarly activities

He has published over 290 scientific manuscripts, and, as a Visiting Professor, has delivered numerous prestigious lectures including the Banting and Best Memorial Lecture of the International Diabetes Federation (1991), the Pfizer Lectures at Harvard University (1993), the Joe Doupe Memorial Lecture at the University of Manitoba (1994), the Novartis lecture of the Canadian Society of Endocrinology and Metabolism (1997), the David M. Kovitz Memorial Lecture at the University of Calgary (2000), the 2nd John & Mary Davidson Lecture (and Award) of the University of Toronto in 2002, and the Volpe Distinguished Service Award of the Canadian Society of Endocrinology and Metabolism (2008).

Recognition and awards

His academic contributions have been recognized by election to the Association of American Physicians (1988), receipt of the Distinguished Scientist Award of the CSCI (1991), election to Fellowship in the Royal Society of Canada, appointment as Officer of the Order of Canada (1999), and receipt of the Queen's Golden Jubilee Medal (2002). In 2014, he was made a Knight of the National Order of Quebec; and in 2015 received the Lifetime Achievement Award of the Canadian Diabetes Association. On his retirement from McGill in 2019 he was awarded the McGill Medal for outstanding academic achievement.

Related Research Articles

<span class="mw-page-title-main">Endocrinology</span> Branch of medicine dealing the endocrine system

Endocrinology is a branch of biology and medicine dealing with the endocrine system, its diseases, and its specific secretions known as hormones. It is also concerned with the integration of developmental events proliferation, growth, and differentiation, and the psychological or behavioral activities of metabolism, growth and development, tissue function, sleep, digestion, respiration, excretion, mood, stress, lactation, movement, reproduction, and sensory perception caused by hormones. Specializations include behavioral endocrinology and comparative endocrinology.

<span class="mw-page-title-main">Insulin</span> Peptide hormone

Insulin is a peptide hormone produced by beta cells of the pancreatic islets encoded in humans by the insulin (INS) gene. It is considered to be the main anabolic hormone of the body. It regulates the metabolism of carbohydrates, fats and protein by promoting the absorption of glucose from the blood into liver, fat and skeletal muscle cells. In these tissues the absorbed glucose is converted into either glycogen via glycogenesis or fats (triglycerides) via lipogenesis, or, in the case of the liver, into both. Glucose production and secretion by the liver is strongly inhibited by high concentrations of insulin in the blood. Circulating insulin also affects the synthesis of proteins in a wide variety of tissues. It is therefore an anabolic hormone, promoting the conversion of small molecules in the blood into large molecules inside the cells. Low insulin levels in the blood have the opposite effect by promoting widespread catabolism, especially of reserve body fat.

<span class="mw-page-title-main">Frederick Banting</span> Canadian medical scientist and doctor

Sir Frederick Grant Banting was a Canadian medical scientist, physician, painter, and Nobel laureate noted as the co-discoverer of insulin and its therapeutic potential.

<span class="mw-page-title-main">Bernardo Houssay</span> Argentine physician (1887–1971)

Bernardo Alberto Houssay was an Argentine physiologist. Houssay was a co-recipient of the 1947 Nobel Prize for Physiology or Medicine for discovering the role played by pituitary hormones in regulating the amount of glucose in animals, sharing the prize with Carl Ferdinand Cori and Gerty Cori. He is the first Latin American Nobel laureate in the sciences.

<span class="mw-page-title-main">Zvi Laron</span>

Zvi Laron is an Israeli paediatric endocrinologist. Born in Cernăuţi, Romania, Laron is a professor emeritus at Tel Aviv University. In 1966, he described the type of dwarfism later called Laron syndrome. His research opened the way to the treatment of many cases of growth hormone disorders. He was the first to introduce the multidisciplinary treatment for juvenile diabetes.

<span class="mw-page-title-main">George P. Chrousos</span>

George P. Chrousos is professor of Pediatrics and Endocrinology Emeritus and former chairman of the Department of Pediatrics at the Athens University Medical School, Greece. Earlier he was senior investigator, director of the Pediatric Endocrinology Section and Training Program, and chief of the Pediatric and Reproductive Endocrinology Branch of the National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH). He is also clinical professor of Pediatrics, Physiology and Biophysics at Georgetown University Medical School and distinguished visiting scientist, NICHD, NIH. Dr. Chrousos was the first general director of the Foundation of Biomedical Research of the Academy of Athens (2001–2002). He holds the UNESCO Chair on Adolescent Health Care, while he held the 2011 John Kluge Chair in Technology and Society, Library of Congress, Washington, D.C.

Derek LeRoith is a South African endocrinologist and Professor of Medicine and the current Chief of the Hilda and J. Lester Gabrilove, M.D. Division of Endocrinology, Diabetes and Bone Disease and Director of the Metabolism Institute of the Mount Sinai Medical Center in New York City. He is an international expert in insulin-like growth factor-1 (IGF-1).

Mitchell Lazar is an endocrinologist and physician-scientist known for his discovery of the hormone resistin and his contributions to the transcriptional regulation of metabolism.

Ray Fletcher Farquharson was a Canadian medical doctor, university professor, and medical researcher. Born in Claude, Ontario, he attended and taught at the University of Toronto for most of his life, and was trained and employed at Toronto General Hospital. With co-researcher Arthur Squires, Farquharson was responsible for the discovery of the Farquharson phenomenon, an important principle of endocrinology, which is that administering external hormones suppresses the natural production of that hormone.

<span class="mw-page-title-main">Leonid Poretsky</span> American endocrinologist

Leonid Poretsky is a Russian-born American endocrinologist. His research interests include mechanisms of insulin action in the ovary, endocrinological aspects of AIDS, and clinical outcomes in diabetes. He has authored over 150 publications and has served on the National Institutes of Health's review committees and on the editorial boards of the Journal of Clinical Endocrinology and Metabolism and other endocrine journals.

<span class="mw-page-title-main">C. Ronald Kahn</span> American physician and scientist

Carl Ronald Kahn is an American physician and scientist, best known for his work with insulin receptors and insulin resistance in diabetes and obesity. He is the Chief Academic Officer at Joslin Diabetes Center, the Mary K. Iacocca Professor of Medicine at Harvard Medical School and a member of the National Academy of Sciences since 1999.

<span class="mw-page-title-main">Jose F. Caro</span> American physician

José F. Caro is an American physician, scientist, and educator most notable for his research in obesity and diabetes. The Institute for Scientific Information listed him the third most cited investigator in the world in the field of obesity research during the 1991-2000 period for his work on Leptin. Caro is an artist and a signature member of the Pastel Society of America.

Mladen Vranic, MD, DSc, O.C., O.Ont, FRSC, FRCP(C), FCAHS, Canadian Medical Hall of Fame[CMHF] April 3, 1930 – June 18, 2019, was a Croatian-born diabetes researcher, best known for his work in tracer methodology, exercise and stress in diabetes, the metabolic effects of hormonal interactions, glucagon physiology, extrapancreatic glucagon, the role of the direct and indirect metabolic effects of insulin and the prevention of hypoglycemia. Vranic was recognized by a number of national and international awards for his research contributions, mentoring and administration including the Orders of Canada (Officer) and Ontario.

<span class="mw-page-title-main">Matthias Tschöp</span> German neuroendocrinologist (born 1967)

Matthias H. Tschöp is a German physician and scientist. He is the chief executive officer and scientific director of Helmholtz Zentrum München, German Research Center for Environmental Health. He is also Alexander von Humboldt Professor and chair of metabolic diseases at Technical University of Munich and serves as an adjunct professor at Yale University.

<span class="mw-page-title-main">Daniel J. Drucker</span> Canadian endocrinologist (born 1956)

Daniel Joshua Drucker is a Canadian endocrinologist. A Fellow of the Royal Society, he is a professor of medicine at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto. He is known for his research into intestinal hormones and their use in the treatment of diabetes and other metabolic diseases.

Ora Mendelsohn Rosen was an American medical researcher who investigated the influence of hormones, particularly insulin, on the control of cell growth. She was a professor at the Albert Einstein College of Medicine and Memorial Sloan Kettering Cancer Center and a member of the National Academy of Sciences.

<span class="mw-page-title-main">Gökhan S. Hotamisligil</span> American geneticist

Gökhan S. Hotamisligil is a Turkish-American physician scientist; James Stevens Simmons Chair of Genetics and Metabolism at Harvard T.H. Chan School of Public Health (HSPH); Director of the Sabri Ülker Center for Metabolic Research and associate member of Harvard-MIT Broad Institute, Harvard Stem Cell Institute and the Joslin Diabetes Center.

David Goltzman is an endocrinologist, Professor of Medicine and Physiology, and A.G. Massabki Chair in Medicine at McGill University in Montreal, Quebec, Canada. He has been the Director of the Centre for Bone and Periodontal Research and also holds the position of Senior Scientist at the McGill University Health Centre Research Institute in the Metabolic Disorders and Complications Program.

John J. M. Bergeron, is a Canadian cell biologist and biochemist. He is an Emeritus Robert Reford Professor of Anatomy and Professor of Medicine at McGill University in Montreal, Quebec, Canada. He is a Rhodes Scholar. He is best known for the discovery of calnexin, endosomal signalling and organellar proteomics.

Barbara B. Kahn is an endocrinologist and the George Richards Minot professor of medicine at Harvard Medical School. She is also the vice chair for research strategy in the department of medicine at Beth Israel Deaconess Medical Center, and was formerly the chief of the Division of Endocrinology, Diabetes, and Metabolism at Beth Israel Deaconess. Her research focuses on insulin resistance and type 2 diabetes.

References